Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of

Sining Shen1, Ke Li2, Ying Liu2

  • 1Department of Thoracic Surgery, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, P.R. China.

Insights

Targeting AGAP2-AS1, a long non-coding RNA, can suppress esophageal cancer (EC) progression. This involves upregulating miR-195-5p and downregulating FOSL1, offering a potential new therapeutic strategy for EC.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • RNA Biology

Background:

  • Long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) interactions are crucial in cancer development.
  • Esophageal cancer (EC) progression is influenced by complex molecular pathways.
  • Understanding the specific roles of lncRNA/miRNA/mRNA axes is vital for targeted therapies.

Purpose of the Study:

  • To investigate the role of the AGAP2-AS1/miR-195-5p/FOSL1 axis in esophageal cancer (EC) progression.
  • To elucidate the molecular mechanisms underlying EC development involving these key molecules.
  • To evaluate the therapeutic potential of targeting this axis in EC.

Main Methods:

  • Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to determine expression levels of AGAP2-AS1, miR-195-5p, and FOSL1.
  • In vitro experiments including ectopic expression, knockdown, and reporter assays to study cellular processes.
  • In vivo studies to assess the effect of AGAP2-AS1 silencing on tumor growth.

Main Results:

  • AGAP2-AS1 and FOSL1 were upregulated, while miR-195-5p was downregulated in EC tissues and cell lines.
  • AGAP2-AS1 knockdown or miR-195-5p overexpression inhibited EC cell proliferation, migration, and invasion, and promoted apoptosis.
  • miR-195-5p directly targets FOSL1, and AGAP2-AS1 upregulates FOSL1 by sponging miR-195-5p.

Conclusions:

  • AGAP2-AS1 promotes EC development by upregulating FOSL1 via sponging miR-195-5p.
  • Silencing AGAP2-AS1 restrains EC progression both in vitro and in vivo.
  • Targeting AGAP2-AS1 represents a promising therapeutic strategy for esophageal cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
Cell Migration01:19

Cell Migration

Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
6.2K